Skip to main content
Clinical Trials/NCT02694380
NCT02694380
Terminated
Not Applicable

Measuring the Effect of Radiation Therapy on Patient Activity Levels

University of Pittsburgh2 sites in 1 country32 target enrollmentJuly 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
University of Pittsburgh
Enrollment
32
Locations
2
Primary Endpoint
Activity level
Status
Terminated
Last Updated
7 years ago

Overview

Brief Summary

The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.

Detailed Description

At the University of Pittsburgh (UPMC) St. Margaret and UPMC Shadyside, in the department of radiation oncology, breast, prostate, head and neck, and lung cancer patients will receive the standard treatment for their cancer and in no way will this study interfere with this treatment. Prior to initiation of radiation, consenting patients will be given Misfit activity tracking devices (accelerometers) to be worn on their wrist to track their activity levels throughout the course radiation therapy. Bracelets will be given to patients by the PI or co-investigators (MDs involved in patient's care) at date of consent and returned at completion of the study. The bracelets will track daily steps taken, calories burned, miles walked, and restful and restless sleep. Again, the purpose of the study is merely to measure the affect radiation therapy has on activity levels of patients.

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
July 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Colin E. Champ, MD

Assistant Clinical Professor University of Pittsburgh Radiation Oncology

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Breast, Prostate, Lung or Head and Neck Cancer
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
  • Ability to walk 100 feet without rest
  • Signed informed consent

Exclusion Criteria

  • Any other noncutaneous cancer diagnosis under active treatment
  • Known metastatic disease

Outcomes

Primary Outcomes

Activity level

Time Frame: up to 15 weeks

Misfit activity tracking devices (accelerometers) will be worn by patients to track their activity levels 1 day to 4 weeks before radiotherapy, during radiotherapy, and for 1 day to 4 weeks after radiotherapy.

Study Sites (2)

Loading locations...

Similar Trials